➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
McKesson
Merck
Johnson and Johnson
Baxter

Last Updated: December 2, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Cavosonstat

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Cavosonstat?

Cavosonstat is an investigational drug.

There have been 9 clinical trials for Cavosonstat. The most recent clinical trial was a Phase 1 trial, which was initiated on April 1st 2016.

The most common disease conditions in clinical trials are Cystic Fibrosis, Fibrosis, and Pulmonary Disease, Chronic Obstructive. The leading clinical trial sponsors are Nivalis Therapeutics, Inc., GSNOR Therapeutics, Inc., and University of North Carolina, Chapel Hill.

There are ten US patents protecting this investigational drug and forty-six international patents.

Recent Clinical Trials for Cavosonstat
TitleSponsorPhase
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Cavosonstat Administered Twice Daily Compared With Placebo for 24 Weeks in Adult Subjects With Chronic Obstructive Pulmonary DisGSNOR Therapeutics, Inc.Phase 2
PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network StudyNational Heart, Lung, and Blood Institute (NHLBI)Phase 2
PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network StudyUniversity of North Carolina, Chapel HillPhase 2

See all Cavosonstat clinical trials

Clinical Trial Summary for Cavosonstat

Top disease conditions for Cavosonstat
Top clinical trial sponsors for Cavosonstat

See all Cavosonstat clinical trials

US Patents for Cavosonstat

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Cavosonstat   Start Trial Solid forms of an S-Nitrosoglutathione reductase inhibitor LAUREL THERAPEUTICS LTD. (Hangzhou, Zhejiang Province, CN)   Start Trial
Cavosonstat   Start Trial Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors N30 Pharmaceuticals, Inc. (Boulder, CO)   Start Trial
Cavosonstat   Start Trial Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors N30 Pharmaceuticals, Inc. (Boulder, CO)   Start Trial
Cavosonstat   Start Trial Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors Nivalis Therapeutics, Inc. (Boulder, CO)   Start Trial
Cavosonstat   Start Trial Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors Nivalis Therapeutics, Inc. (Boulder, CO)   Start Trial
Cavosonstat   Start Trial Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors Nivalis Therapeutics, Inc. (Boulder, CO)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Cavosonstat

Drugname Country Document Number Estimated Expiration Related US Patent
Cavosonstat World Intellectual Property Organization (WIPO) WO2017044766 2035-09-10   Start Trial
Cavosonstat World Intellectual Property Organization (WIPO) WO2017044788 2035-09-10   Start Trial
Cavosonstat Australia AU2011343518 2030-12-16   Start Trial
Cavosonstat Brazil BR112013014681 2030-12-16   Start Trial
Cavosonstat Canada CA2821412 2030-12-16   Start Trial
Cavosonstat China CN103328430 2030-12-16   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
McKesson
Merck
Johnson and Johnson
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.